{"id":23714,"date":"2026-06-13T15:55:25","date_gmt":"2026-06-13T15:55:25","guid":{"rendered":"https:\/\/weitaibiotech.com\/?p=23714"},"modified":"2026-06-13T15:55:25","modified_gmt":"2026-06-13T15:55:25","slug":"glp1-ozempic-face-post-weight-loss-skincare-oem","status":"publish","type":"post","link":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/","title":{"rendered":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare"},"content":{"rendered":"<h2>The Ozempic Face Phenomenon<\/h2>\n<p>GLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.<\/p>\n<h2>Ozempic Face Characteristics<\/h2>\n<ul>\n<li><strong>Volume loss:<\/strong> Hollowed cheeks, temples, orbits<\/li>\n<li><strong>Skin laxity:<\/strong> Loose, sagging skin unable to contract<\/li>\n<li><strong>Accelerated aging:<\/strong> Sudden wrinkles, fine lines, jowls<\/li>\n<li><strong>Volume redistribution:<\/strong> Loss of facial definition<\/li>\n<li><strong>Pre-mature aging:<\/strong> Often 5-10 years older appearance<\/li>\n<\/ul>\n<h2>Market Data<\/h2>\n<p>Search interest for Ozempic face grew 250%+ year-over-year (Google Trends 2025). Related searches: skin tightening, facial fillers, PDO threads all increased significantly.<\/p>\n<h2>OEM Product Opportunities<\/h2>\n<ul>\n<li><strong>HA dermal fillers:<\/strong> Most direct solution; OEM injectable products<\/li>\n<li><strong>Topical plumping serums:<\/strong> HA + peptides for surface volume<\/li>\n<li><strong>PN\/PDRN skin boosters:<\/strong> For skin quality improvement<\/li>\n<li><strong>Radiofrequency-compatible serums:<\/strong> For RF microneedling pairing<\/li>\n<li><strong>Tightening creams:<\/strong> Peptides + retinoids + ceramides<\/li>\n<li><strong>Hair loss serums:<\/strong> GLP-1 also causes telogen effluvium<\/li>\n<\/ul>\n<h2>Target Markets<\/h2>\n<p>Primary markets: USA (highest GLP-1 adoption), UK, Australia, UAE, Saudi Arabia \u2014 also highest aesthetic spending markets.<\/p>","protected":false},"excerpt":{"rendered":"<p>The Ozempic Face Phenomenon GLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight)<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-23714","post","type-post","status-publish","format-standard","hentry","category-blog"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 4.9.0 - aioseo.com -->\n\t<meta name=\"description\" content=\"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"info@weitaibiotech.com\"\/>\n\t<meta name=\"google-site-verification\" content=\"P1Y1aqx8s5CQd0LW6d3HOrmXyWsd7ltH7H4J-yrxXlc\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 4.9.0\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Guangdong Weitai Biotechnology Co., LTD -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD\" \/>\n\t\t<meta property=\"og:description\" content=\"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-06-13T15:55:25+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-13T15:55:25+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61584028118520\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD\" \/>\n\t\t<meta name=\"twitter:description\" content=\"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#blogposting\",\"name\":\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD\",\"headline\":\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare\",\"author\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/author\\\/supportmyrisesun-com\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/#organization\"},\"datePublished\":\"2026-06-13T15:55:25+00:00\",\"dateModified\":\"2026-06-13T15:55:25+00:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#webpage\"},\"articleSection\":\"BLOG\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/weitaibiotech.com\\\/id\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/category\\\/blog\\\/#listItem\",\"name\":\"BLOG\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/category\\\/blog\\\/#listItem\",\"position\":2,\"name\":\"BLOG\",\"item\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/category\\\/blog\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#listItem\",\"name\":\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#listItem\",\"position\":3,\"name\":\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/category\\\/blog\\\/#listItem\",\"name\":\"BLOG\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/#organization\",\"name\":\"Guangdong Weitai Biotechnology Co., LTD\",\"url\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/\",\"telephone\":\"+8613527987268\",\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61584028118520\",\"https:\\\/\\\/www.tiktok.com\\\/@weitai_tech?_r=1&_t=ZP-97AgHLTCJJf\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/author\\\/supportmyrisesun-com\\\/#author\",\"url\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/author\\\/supportmyrisesun-com\\\/\",\"name\":\"info@weitaibiotech.com\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#authorImage\",\"url\":\"https:\\\/\\\/weitaibiotech.com\\\/wp-content\\\/litespeed\\\/avatar\\\/5dbbd65c6eaaec2d9b8703ab3b000861.jpg?ver=1784953448\",\"width\":96,\"height\":96,\"caption\":\"info@weitaibiotech.com\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#webpage\",\"url\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/\",\"name\":\"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD\",\"description\":\"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/glp1-ozempic-face-post-weight-loss-skincare-oem\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/author\\\/supportmyrisesun-com\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/author\\\/supportmyrisesun-com\\\/#author\"},\"datePublished\":\"2026-06-13T15:55:25+00:00\",\"dateModified\":\"2026-06-13T15:55:25+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/#website\",\"url\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/\",\"name\":\"Guangdong Weitai Biotechnology Co., LTD\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/weitaibiotech.com\\\/id\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD<\/title>\n\n","aioseo_head_json":{"title":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD","description":"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:","canonical_url":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"P1Y1aqx8s5CQd0LW6d3HOrmXyWsd7ltH7H4J-yrxXlc","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#blogposting","name":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD","headline":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare","author":{"@id":"https:\/\/weitaibiotech.com\/id\/author\/supportmyrisesun-com\/#author"},"publisher":{"@id":"https:\/\/weitaibiotech.com\/id\/#organization"},"datePublished":"2026-06-13T15:55:25+00:00","dateModified":"2026-06-13T15:55:25+00:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#webpage"},"isPartOf":{"@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#webpage"},"articleSection":"BLOG"},{"@type":"BreadcrumbList","@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id#listItem","position":1,"name":"Home","item":"https:\/\/weitaibiotech.com\/id","nextItem":{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id\/category\/blog\/#listItem","name":"BLOG"}},{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id\/category\/blog\/#listItem","position":2,"name":"BLOG","item":"https:\/\/weitaibiotech.com\/id\/category\/blog\/","nextItem":{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#listItem","name":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare"},"previousItem":{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#listItem","position":3,"name":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare","previousItem":{"@type":"ListItem","@id":"https:\/\/weitaibiotech.com\/id\/category\/blog\/#listItem","name":"BLOG"}}]},{"@type":"Organization","@id":"https:\/\/weitaibiotech.com\/id\/#organization","name":"Guangdong Weitai Biotechnology Co., LTD","url":"https:\/\/weitaibiotech.com\/id\/","telephone":"+8613527987268","sameAs":["https:\/\/www.facebook.com\/profile.php?id=61584028118520","https:\/\/www.tiktok.com\/@weitai_tech?_r=1&_t=ZP-97AgHLTCJJf"]},{"@type":"Person","@id":"https:\/\/weitaibiotech.com\/id\/author\/supportmyrisesun-com\/#author","url":"https:\/\/weitaibiotech.com\/id\/author\/supportmyrisesun-com\/","name":"info@weitaibiotech.com","image":{"@type":"ImageObject","@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#authorImage","url":"https:\/\/weitaibiotech.com\/wp-content\/litespeed\/avatar\/5dbbd65c6eaaec2d9b8703ab3b000861.jpg?ver=1784953448","width":96,"height":96,"caption":"info@weitaibiotech.com"}},{"@type":"WebPage","@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#webpage","url":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/","name":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD","description":"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/weitaibiotech.com\/id\/#website"},"breadcrumb":{"@id":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/#breadcrumblist"},"author":{"@id":"https:\/\/weitaibiotech.com\/id\/author\/supportmyrisesun-com\/#author"},"creator":{"@id":"https:\/\/weitaibiotech.com\/id\/author\/supportmyrisesun-com\/#author"},"datePublished":"2026-06-13T15:55:25+00:00","dateModified":"2026-06-13T15:55:25+00:00"},{"@type":"WebSite","@id":"https:\/\/weitaibiotech.com\/id\/#website","url":"https:\/\/weitaibiotech.com\/id\/","name":"Guangdong Weitai Biotechnology Co., LTD","inLanguage":"id-ID","publisher":{"@id":"https:\/\/weitaibiotech.com\/id\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Guangdong Weitai Biotechnology Co., LTD -","og:type":"article","og:title":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD","og:description":"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:","og:url":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/","article:published_time":"2026-06-13T15:55:25+00:00","article:modified_time":"2026-06-13T15:55:25+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61584028118520","twitter:card":"summary_large_image","twitter:title":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare - Guangdong Weitai Biotechnology Co., LTD","twitter:description":"The Ozempic Face PhenomenonGLP-1 receptor agonists (semaglutide, tirzepatide) have 15M+ US prescriptions (2024). Dramatic weight loss (15-30% body weight) creates characteristic aesthetic side effects generating a new skincare category.Ozempic Face CharacteristicsVolume loss: Hollowed cheeks, temples, orbitsSkin laxity: Loose, sagging skin unable to contractAccelerated aging: Sudden wrinkles, fine lines, jowlsVolume redistribution: Loss of facial definitionPre-mature aging:"},"aioseo_meta_data":{"post_id":"23714","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"seo_analyzer_scan_date":"2026-06-13 16:41:13","breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2026-06-13 15:55:25","updated":"2026-06-13 16:41:13"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/weitaibiotech.com\/id\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/weitaibiotech.com\/id\/category\/blog\/\" title=\"BLOG\">BLOG<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tGLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/weitaibiotech.com\/id"},{"label":"BLOG","link":"https:\/\/weitaibiotech.com\/id\/category\/blog\/"},{"label":"GLP-1 Ozempic Face: New OEM Opportunities in Post-Weight Loss Skincare","link":"https:\/\/weitaibiotech.com\/id\/glp1-ozempic-face-post-weight-loss-skincare-oem\/"}],"_links":{"self":[{"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/posts\/23714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/comments?post=23714"}],"version-history":[{"count":1,"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/posts\/23714\/revisions"}],"predecessor-version":[{"id":23715,"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/posts\/23714\/revisions\/23715"}],"wp:attachment":[{"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/media?parent=23714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/categories?post=23714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/weitaibiotech.com\/id\/wp-json\/wp\/v2\/tags?post=23714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}